Olio Labs
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
Y Combinator
yc-company-directory #2464Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
sourceOlio Labs is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Olio Labs
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Abalone Bio
match 73Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. + High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of o
shared product terms: target, drug, obesity, side; shared product theme: health and clinical care; same category: AI infrastructure; shared affiliation: Y Combinator
OpenFunnel
match 44OpenFunnel is the Search Engine for GTM. Searching for "B2B SaaS, 501-1000 employees, uses Salesforce" - is just targeted spam. Even if you get creative with LLMs to query these databases, everyone has access to the same commoditized databases, these databases lack insights about right timing or pain-points prospects face. OpenFunnel is a time-aware search engine for insights and activities in your target segment - that reveal pain. You can search for activities like: "Find companies looking to
shared product terms: uses, target, just, time; same category: AI infrastructure; shared affiliation: Y Combinator
Gilgamesh Pharmaceuticals
match 38Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.
shared product terms: develop, combination, drug, expertise; shared product theme: health and clinical care; shared affiliation: Y Combinator
Phiar
match 36At Phiar, we are building the first AI-powered AR navigation driving software solution that runs on a smartphone and in-vehicle displays, utilizing our ultra-lightweight road understanding AI that runs completely at-the-edge, in real-time, all on just a smartphone-level compute. Our mission is to enhance driving safety, facilitate more intuitive wayfinding, and connect drivers with their surrounding environments.
shared product terms: edge, real, time, just; same category: AI infrastructure; shared affiliation: Y Combinator
Shasqi
match 30Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.
shared product terms: lead, therapeutic, two; shared product theme: health and clinical care; shared affiliation: Y Combinator
Curated for You
match 24dearduck Helping you find the perfect presents, every time.
shared product terms: find, perfect, time